SearchSearch
Navigacija
Navigacija
Monday, 24 March 2025 11:26

Workshop on Preclinical Models of MASLD

The STRIMHealth team at the University of Belgrade – Institute for Biological Research “Siniša Stanković” is pleased to announce the Workshop on Preclinical Models of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). The workshop will take place on-site at the IBISS Library, Belgrade, Serbia, from April 8–10, 2025.

The Intellectual Property Office of the Republic of Serbia has published an accepted patent under the designation RS 66375 B1, the application of which has gone through all legal and technical processes, and the Office has approved it as valid.

As part of the activities of the STRIMHealth project to improve translational research in the field of metabolic diseases, we are pleased to announce the course Translational Research in Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD), which will take place on April 7, 2025 at the Institute for Biological Research “Siniša Stanković", Belgrade, Serbia. Participation is possible both on-site at the IBISS library and online.

Dr. Nataša Veličković, coordinator of the STRIMHealth project, participated as an invited speaker in the lecture series organized within the PFAStwin project. Her lecture “The Impact of PFAS on the Development of Metabolic Diseases,” was held on March 18 in the Small Hall of the Kolarac Foundation.

The two-day online workshop, organized within the STRIMHealth project to strengthen collaboration between IBISS and European universities, has been successfully completed.

On Wednesday, March 12, 2025, the conference "Scientific research projects tailored to business - experiences and opportunities in the pharmaceutical industry" was held at the Serbian Chamber of Commerce. During the meeting, Dr. Ana Đorđević presented the potential of IBISS for cooperation with the pharmaceutical industry, as well as the ongoing collaborative UTRL project "LiverDophilus - Probiotic bacteria for the treatment of liver steatosis", which is funded through SAIGE and realized through the cooperation between IBISS, IMGGI and the pharmaceutical company Phytonet.

On March 11-12, 2025, the Institute for Biological Research “Siniša Stanković” hosted an intensive hands-on training session focused on mass spectrometry data processing in lipidomics. This training was a sort of continuation and deepening of the Training in Analytical Methods for Mass Spectrometry-based Lipidomics held in October of the previous year, aimed at engaging participants more actively with real research datasets.

The first training on EU research funding and project management, organized as part of the STRIMHealth project, has been successfully completed. Held at IBISS on March 10th, Belgrade, the training covered key topics on funding opportunities and the grant preparation process.

Thursday, 27 February 2025 11:07

Workshop on Research Data Management

As part of the STRIMHealth project activities aimed at enhancing project proposal writing and the implementation of EU-funded projects, we are pleased to announce the Workshop on Research Data Management (RDM). The workshop will be held online on March 17–18, 2025.

Wednesday, 19 February 2025 15:41

Marija Pinjić

Marija Pinjić completed her B.Sc. in 2022 at the Faculty of Biology, University of Belgrade, majoring in Molecular Biology and Physiology, with an average grade of 9.59. She earned her Master's degree in Genomics at the same faculty in 2023 by defending her thesis titled "Polymerase chain reaction as an enrichment method for analysis of DMPK expansions in patients with congenital form of myotonic dystrophy type 1" achieving an average grade of 10.00. The experimental part of her master's thesis was completed at the Human Molecular Genetics, Faculty of Biology, University of Belgrade.

In October of 2024, she enrolled in the Ph.D. program of Animal and Human Physiology and obtained the title of Junior Research Assistant.

As of February 1, 2025, she has been employed at the Department of Neurophysiology, where she will complete her doctoral dissertation.

Throughout her scientific career and professional development, Marija has chosen to focus on the molecular and cellular mechanisms underlying neurodegenerative and malignant diseases, as well as the investigation of novel therapeutics for these conditions using the latest biochemical and molecular methods. Her research will be dedicated to uncovering the roles and regulatory mechanisms of autophagy, oxidative stress, mitochondria, and cell death as potential therapeutic targets.

Understanding the physiological and functional characteristics of cancer cells at the individual level, and the tumor tissue as a highly orchestrated multicellular formation, by whose activity the tumor expands, invades and disseminates, is the main goal of cancer biology research today. Defining the causes of abnormal behavior of neoplastic cells individually and in the context of the tumor microenvironment, including the histological, metabolic and immunological specificities of this tissue, represents a platform for designing new approaches in cancer treatment. Investigating the phenomenon of initial or acquired tumor resistance helps to gain deeper insights into the reasons for limited effects of the conventional treatments, enabling the improvement of existing protocols.

Neurobiology studies the anatomy, physiology, and pathology of the nervous system. From the molecular and biochemical basis of this system, to the study of behavioral plasticity, to understanding the driving forces of neurodegenerative diseases and how they can be treated. Electrophysiology studies biophysical properties in vertebrate neurons and links morphofunctional features of the brain to observed animal behavior. The ultimate goal is to identify active substances that may have a protective effect in neurological and psychiatric diseases.

Page 2 of 34
Cookie notice

IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.